scholarly journals Impact of Congenital Heart Disease on Brain Development and Neurodevelopmental Outcome

2010 ◽  
Vol 2010 ◽  
pp. 1-13 ◽  
Author(s):  
Mary T. Donofrio ◽  
An N. Massaro

Advances in cardiac surgical techniques and perioperative intensive care have led to improved survival in babies with congenital heart disease (CHD). While it is true that the majority of children with CHD today will survive, many will have impaired neurodevelopmental outcome across a wide spectrum of domains. While continuing to improve short-term morbidity and mortality is an important goal, recent and ongoing research has focused on defining the impact of CHD on brain development, minimizing postnatal brain injury, and improving long-term outcomes. This paper will review the impact that CHD has on the developing brain of the fetus and infant. Neurologic abnormalities detectable prior to surgery will be described. Potential etiologies of these findings will be discussed, including altered fetal intrauterine growth, cerebral blood flow and brain development, associated congenital brain abnormalities, and risk for postnatal brain injury. Finally, reported neurodevelopmental outcomes after surgical repair of CHD will be reviewed.


2016 ◽  
Vol 170 (4) ◽  
pp. e154450 ◽  
Author(s):  
Shabnam Peyvandi ◽  
Veronica De Santiago ◽  
Elavazhagan Chakkarapani ◽  
Vann Chau ◽  
Andrew Campbell ◽  
...  








PEDIATRICS ◽  
2017 ◽  
Vol 140 (1) ◽  
pp. e20164055 ◽  
Author(s):  
Mirthe J. Mebius ◽  
Elisabeth M.W. Kooi ◽  
Catherina M. Bilardo ◽  
Arend F. Bos


2020 ◽  
Vol 75 (11) ◽  
pp. 625
Author(s):  
Whitnee Hogan ◽  
Yensy Zetino ◽  
Patrick McQuillen ◽  
Shabnam Peyvandi


Author(s):  
Samantha D. Roberts ◽  
Vanna Kazazian ◽  
Meghan K. Ford ◽  
Davide Marini ◽  
Steven P. Miller ◽  
...  


2020 ◽  
pp. 1-8
Author(s):  
Rohit S. Loomba ◽  
Jacqueline Rausa ◽  
Vincent Dorsey ◽  
Ronald A. Bronicki ◽  
Enrique G. Villarreal ◽  
...  

Abstract Introduction: Children with congenital heart disease and cardiomyopathy are a unique patient population. Different therapies continue to be introduced with large practice variability and questionable outcomes. The purpose of this study is to determine the impact of various medications on intensive care unit length of stay, total length of stay, billed charges, and mortality for admissions with congenital heart disease and cardiomyopathy. Materials and methods: We identified admissions of paediatric patients with cardiomyopathy using the Pediatric Health Information System database. The admissions were then separated into two groups: those with and without inpatient mortality. Univariate analyses were conducted between the groups and the significant variables were entered as independent variables into the regression analyses. Results: A total of 10,376 admissions were included these analyses. Of these, 904 (8.7%) experienced mortality. Comparing patients who experienced mortality with those who did not, there was increased rate of acute kidney injury with an odds ratio (OR) of 5.0 [95% confidence interval (CI) 4.3 to 5.8, p < 0.01], cardiac arrest with an OR 7.5 (95% CI 6.3 to 9.0, p < 0.01), and heart transplant with an OR 0.3 (95% CI 0.2 to 0.4, p < 0.01). The medical interventions with benefit for all endpoints after multivariate regression analyses in this cohort are methylprednisolone, captopril, enalapril, furosemide, and amlodipine. Conclusions: Diuretics, steroids, angiotensin-converting enzyme inhibitors, calcium channel blockers, and beta blockers all appear to offer beneficial effects in paediatric cardiomyopathy admission outcomes. Specific agents within each group have varying effects.



Sign in / Sign up

Export Citation Format

Share Document